Therapy Areas: Diabetes
7 April 2020 - - US-based biopharmaceutical company Millendo Therapeutics, Inc. (NASDAQ: MLND) is discontinuing the development of livoletide as a potential treatment for Prader-Willi syndrome, t...
2 April 2020 - - The Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) Phase III trial for FARXIGA (dapagliflozin) in p...
23 March 2020 - Zealand Pharma A/S (Zealand) (CPH:ZEAL), a biotechnology company focused on the discovery and development of innovative peptide-based medicines, announced on Friday the return by Boehr...
17 March 2020 - - US-based connected care platform provider Vivify Health has launched a new COVID-19 Screening, Self-Isolation and Monitoring Pathways for its Vivify +Go mobile solution, as part of i...
13 March 2020 - - The US Food and Drug Administration has granted Fast Track designation for the investigation of empagliflozin to reduce the risk of kidney disease progression and cardiovascular deat...
13 March 2020 - Provention Bio Inc (Nasdaq: PRVB), a clinical-stage biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, announced on Thursday, its financial re...